With an Italian shareholder base and approximately 1bn USD in net asset value, Genextra is one of Italy’s largest and most experienced life sciences investment firms.
Founded in 2004, Genextra is focused on seeking and fostering the development of life sciences investment opportunities and on assisting in building the infrastructure and management teams that facilitate growth.
With no territory limit but benefiting from preferential access to top quality Italian based science, Genextra selects investment opportunities where it can ensure shareholder and management support.
From its offices in Milan, Genextra’s team aims to back inventors who appreciate the support of an experienced investor, not only providing capital but also offering strategic, operational, financial guidance and support.
The combination of broad experience in the capital markets and access to an extensive network of scientific and industry experts places Genextra in a unique spot to identify exceptional investment opportunities and shepherd them to maturity.